Birth Control Drugs Cause Breast Cancer: Learn the Terrible Truth
Younger women have faced increasing rates of breast cancer for forty years
The headlines keep rolling in. “Breast cancer is increasing 1% to 2% per year in US women under fifty years old”; “Cancer rates are rising for women under 40. Why?”
But guess what?! This “historical/unprecedented” rise in pre-menopausal breast cancer has been going on since the early 1980’s.
In Massachusetts the state cancer board tells us that women under 50 years old struggled with a 2.34% average annual increase in invasive breast tumors, going from 55 tumors per 100,00 younger women in 1985 to 83 tumors per 100,000 younger women in 2008. Meanwhile, according to the Colorado state cancer board, younger women in their state faced about a 1% annual increase up from 60 primary tumors per 100,000 women in 1985, reaching 70 primary tumors per 100,000 in 2008. So it is not at all surprising that the number of pre-menopausal women in the US, being diagnosed with breast cancer, continues to rise by 1%-2% annually. And sadly, much of this increase over the past forty years has to do with that chemical form of progesterone… called PROGESTIN….found in ALL hormonal birth control drugs and hormone-laced IUDS (intrauterine devices) But why do our government health agencies and cancer clinics keep ignoring this elephant in the room? … this elephant named PROGESTIN!
This is not a nice story.
Best to first read the October 1, 2010 press release announcing findings from a ten year study conducted by an international panel of five-star oncology researchers. The lead researcher, Dr Josef Penninger, announced the study’s results via this press release from his Vienna-based Institute for Molecular Biotechnology (IMBA). The title of the press release was “How HRT and the Pill Can Lead to Breast Cancer. ”
The release says: …The … researchers have shown that a synthetic progesterone, frequently used in HRT and hormonal contraception, can switch on the activity of RANKL within breast cells, causing them to divide and multiply and preventing them from dying when they should. “Ten years ago, we formulated the hypothesis that RANKL might be involved in breast cancer and it took us a long time to develop systems to prove this idea,” said Prof Penninger. “I have to admit it completely surprised me just how massive the effects of this system were. Millions of women take progesterone derivatives in contraceptives and for hormonal replacement therapy.” The release also announced that the team’s study had just been published in the highly respected science journal, Nature. “First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ground-breaking discovery” https://www.nature.com/articles/nature09387
The group of researchers behind this discovery included both Dr Penninger, currently the Scientific Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, and Dr Laurie Glimcher, most recently the CEO and President of the Dana Farber Cancer Institute in Boston. Dr Glimcher recently stepped down from her position a few months after researchers discovered she had falsified data on a number of scientific papers she had co-authored in past years. Her 2010 research paper, connecting progestin with the initiation and acceleration of breast cancer, however, was not one of these falsified papers.
It is sad that Dr Glimcher, as former head of one of the world’s foremost cancer treatment centers, has yet to make a public announcement encouraging pre-menopausal women to avoid all hormonal birth control & encouraging older women to avoid using any of the combination menopausal relief drugs now on the market… given progestin’s ability to suffocate breast cells’ mitochondria… too often initiating and sometimes accelerating the growth of existing breast cancer tumors in unsuspecting women who use these progestin drugs.
Has Dr Glimcher’s fifteen year silence about progestin causing breast cancer happened because such an announcement would surely result in plummeting sales of all hormonal contraceptives and combination menopausal relief drugs? After all, worldwide sales of progestin contraceptive drugs, according to Fortune Global Insights, totaled 18.57 billion in 2023, with US sales comprising almost half of this income.
As a board member of Glaxo Smith Kline, until October of 2022, (one of the ten top US manufacturers of hormonal contraceptives), Dr Glimcher continues to remain silent on the connection between these drugs and pre and post menopausal breast cancer. Meanwhile… Dana Farber continues to promote their Young Women with Breast Cancer Program. Founded in 2005 to meet the needs of their increasing number of pre-menopausal breast cancer patients, the program is the first and only one of its kind in New England, having now treated more than 6,000 pre-menopausal women diagnosed with invasive breast cancer.
The global contraceptive drugs market size was valued at USD 18.57 billion in 2023 and is projected to grow from USD 19.80 billion in 2024 to USD 37.22 billion by 2032, exhibiting a CAGR of 8.2% during the forecast period (2024-2032). Moreover, the U.S. contraceptive drugs market size, alone, is projected to grow significantly, reaching an estimated value of USD 12.06 billion by 2032… https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063
Many citations and further information about “how progestin in birth control and some menopausal relief drugs create breast cancer” can be found in Chapters 1 and 3 of my recent book, Busting Breast Cancer: Five Simple Steps to Keep Breast Cancer Out of Your Body. My book also includes a foreword by Dr Thomas N. Seyfried, author of the college text and treatise… Cancer as a Metabolic Disease: On the Origin, Management and Prevention of Cancer, J. Wiley & Sons, 2012.
Autographed launch copies of Busting Breast Cancer (including full-color charts and graphs), can be purchased at bustingbreastcancer.com. Paperback copies and the eBook are available from Amazon, BookShop, Barnes and Noble and all independent bookstores, as well as on all eBook platforms.
Coming up on soon on my Substack:
Why is there only one hormone-free IUD available on the US market (one size fits all with a $1,000+ price tag), while European women have dozens of more effective and safer $30 IUDs available in various makes, models and sizes?
Why and how does that first breast cancer cell get created? How does the recent metabolic theory/understanding of cancer describe the origin of all cancers?
Why and how are some re-purposed drugs effective in helping manage some cancer diagnoses?
Why and how can biopsies of breast tumors or DCIS tissue create metastatic breast cancer?
How many women are developing recurrent metastatic breast cancer each year throughout the US? Why does this number continue to be considered TOP SECRET? Why does the number of women facing a recurrent metastatic breast cancer diagnosis continue to increase each year?
Why and how do women who received the COVID vaccine shots… especially the booster shots.. now face increasing amounts of “turbo breast cancer?”
Why and how are mammograms dangerous?
Need a Copy of Busting Breast Cancer?
Get your copy of Busting Breast Cancer today
Full-color autographed launch copies of the paperback available at: www.bustingbreastcancer.com $20 + $5 shipping.
Also available at:
eBook available on all platforms
Please talk about/ look into all the Instagram doctors who are promoting hrt for perimenopause. They all say it’s perfectly safe and even life-saving. I have no idea what I’m supposed to do.